Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group
- DOI
- 10.1002/hem3.70356
- Published
- 2026-05
- Container
- HemaSphere
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/hem3.70356,
title = {Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group},
author = {Pierre Sesques and Guillaume Manson and Guillaume Cartron and François‐Xavier Gros and Franck Morschhauser and Cristina Castilla‐Llorente and Gabriel Brisou and Pierre Bories and Catherine Thieblemont and Laurianne Drieu La Rochelle and Benoit Tessoulin and Axel André and Cedric Rossi and Jérôme Paillassa and Stephanie Guidez and Antoine Capes and Laura Herbreteau and Sylvain Choquet and Jacques‐Olivier Bay and Adrien Chauchet and Laure Lebras and Fabien Claves and Julie Abraham and Jean‐Valère Malfuson and Marie‐Thérèse Rubio and Justine Decroocq and Luc‐Matthieu Fornecker and Gandhi Damaj and Ludovic Fouillet and Magalie Joris and Michael Loschi and Olivier Hermine and Hadia Hafirassou and Emelie Van Zele and Vivien Dupont and Steven Le Gouill and Roch Houot and Vincent Camus},
year = {2026},
journal = {HemaSphere},
doi = {10.1002/hem3.70356},
url = {https://doi.org/10.1002/hem3.70356}
}RIS
TY - JOUR TI - Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group AU - Pierre Sesques AU - Guillaume Manson AU - Guillaume Cartron AU - François‐Xavier Gros AU - Franck Morschhauser AU - Cristina Castilla‐Llorente AU - Gabriel Brisou AU - Pierre Bories AU - Catherine Thieblemont AU - Laurianne Drieu La Rochelle AU - Benoit Tessoulin AU - Axel André AU - Cedric Rossi AU - Jérôme Paillassa AU - Stephanie Guidez AU - Antoine Capes AU - Laura Herbreteau AU - Sylvain Choquet AU - Jacques‐Olivier Bay AU - Adrien Chauchet AU - Laure Lebras AU - Fabien Claves AU - Julie Abraham AU - Jean‐Valère Malfuson AU - Marie‐Thérèse Rubio AU - Justine Decroocq AU - Luc‐Matthieu Fornecker AU - Gandhi Damaj AU - Ludovic Fouillet AU - Magalie Joris AU - Michael Loschi AU - Olivier Hermine AU - Hadia Hafirassou AU - Emelie Van Zele AU - Vivien Dupont AU - Steven Le Gouill AU - Roch Houot AU - Vincent Camus PY - 2026 JO - HemaSphere DO - 10.1002/hem3.70356 UR - https://doi.org/10.1002/hem3.70356 ER -
APA
Sesques, P., Manson, G., Cartron, G., Gros, F., Morschhauser, F., Castilla‐Llorente, C., Brisou, G., Bories, P., Thieblemont, C., Rochelle, L. D. L., Tessoulin, B., André, A., Rossi, C., Paillassa, J., Guidez, S., Capes, A., Herbreteau, L., Choquet, S., Bay, J., Chauchet, A., Lebras, L., Claves, F., Abraham, J., Malfuson, J., Rubio, M., Decroocq, J., Fornecker, L., Damaj, G., Fouillet, L., Joris, M., Loschi, M., Hermine, O., Hafirassou, H., Zele, E. V., Dupont, V., Gouill, S. L., Houot, R., & Camus, V. (2026). Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group. HemaSphere. https://doi.org/10.1002/hem3.70356
Source records
- crossref · retrieved 2026-09-27T08:09:31.051Z